Skip to main content

Table 2 Histopathological characteristics

From: MDM2 gene SNP309 T/G and p53gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians

number

(%)

Histopathological diagnosis (REAL-classification)

284

91.32

B-cell lymphomas

205

65.92

Diffuse large B-cell lymphoma

13

4,18

DLBCL, NOS

8

2.57

anaplastic large-cell (ALC)

46

14.79

centroblastic diffuse, NOS

16

5.14

centroblastic diffuse, NOS -> monomorphic

9

2.89

centroblastic diffuse, NOS -> multi-lobulated

89

28.62

centroblastic diffuse, NOS -> polymorphic

17

5.47

immunoblastic

4

1.29

primary mediastinal B-cell lymphoma

3

0.96

T-cell rich B-cell-lymphoma

79

25.40

Non-DLBCL B-cell lymphomas

15

4.82

centroblastic-follicular

6

1.93

centroblastic follicular and diffuse

4

1.29

mantle-cell blastic variant

3

0.96

Burkitt-lymphoma

12

3.86

high-grade Burkitt-like

5

1.61

blastic marginal-zone

16

5.14

not otherwise specified

18

5.79

unclassified (technical reasons)

27

8.68

T-cell lymphomas

20

6.43

anaplastic large-cell

4

1.29

peripheral NOS -> small and large-cell

1

0.32

T-cell-lymphoma (AILD)

2

0.64

not otherwise specified